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j ourna l homepage: www.e lsev ie r .com/ locate /bbamemPrefaceBacterial resistance to antimicrobial peptidesEndogenous cationic antimicrobial peptides (AMPs) belong to the
most ancient and efﬁcient components of innate host defenses. It ap-
pears enigmatic thatmicrobes rarely develop high-level AMP-resistance
mechanisms similar to those that render many therapeutic antibiotics
inefﬁcient after short periods of application. However, it is obvious
that microbes of the natural ﬂora and in particular pathogens, dispose
of mechanisms enabling the reduction of AMP susceptibility to a level
that ensures survival in a host. There is circumstantial evidence that
AMPs and AMP-resistance mechanisms have co-evolved to stabilize a
transient host-pathogen balance that in turn shapes the host's AMP
repertoire (A. Peschel and H.-G. Sahl, The co-evolution of host cationic
antimicrobial peptides and microbial resistance, Nature Reviews Micro-
biology Nat. Rev. Microbiol. 4, 2006, 529–536). Elucidating the underly-
ing principles of the evolution of AMP structures and AMP-resistance
mechanisms could lead to the development of more sustainable antibi-
otics. Therefore, this special issuewas assembled to highlight the variety
of microbial AMP-resistancemechanisms and to discuss their relevance
in the course of an infection.
Miller et al. describe how Salmonella is able to effectively mount
an inducible barrier in its defense against antimicrobial peptides. In
Salmonella, antimicrobial peptide detection initiates a complex regula-
tory cascade that results in the modiﬁcation of its outer membrane
properties coupled to the synthesis of efﬂux pumps and a speciﬁc
protease.
Stephens' studies on Neisseria meningitidis a colonizer of the human
upper respiratory tract revealed that it evolved effective mechanisms
to confer intrinsic and high levels of resistance to the action of AMPs.
The two major resistance mechanisms employed by meningococci
are the constitutive modiﬁcation of the lipid A head groups of
lipooligosaccharides by phosphoethanolamine and the active efﬂux
pump-mediated excretion of AMPs. Other components inﬂuencing
AMP resistance include the major porin (PorB), the pilin biogenesis
apparatus, and capsular polysaccharides. Even with an inherently high
intrinsic resistance, AMP-resistance determinants can be further
induced upon exposure to AMPs, and thus the meningococcus contains
a limited but highly effective set of molecular mechanisms to mediate
antimicrobial peptide resistance.
Lysozyme, discovered by Sir Alexander Fleming in 1922, is probably
the ﬁrst known host defense protein of the innate immune system.
Speciﬁc Gram-negative bacteria can produce so-called Ivy proteins to de-
fend themselves against the cellwall degrading action of lysozyme. In this
special issue, Hans Vogel and colleagues describe detailed structural and
biophysical studies of the Ivy proteins puriﬁed from Escherichia coli and
Pseudomonas aeruginosa and their interactions with human and hen
egg-white lysozyme. They elegantly show that these protein–protein
interactions can play a species-speciﬁc role in human host defense.http://dx.doi.org/10.1016/j.bbamem.2015.08.009
0005-2736/© 2015 Elsevier B.V. All rights reserved.The streptococci are among the top infectious causes of mortality.
These pathogens havemultiplemechanisms for resisting the antimicro-
bial peptides of the innate immune system which are summarized by
Nizet et al. Despite apparent redundancy, the composite of these
mechanisms enables high-level resistance to AMPs that promote
virulence.
Joo and Otto summarize a variety of resistance mechanisms that
the important and frequently drug-resistant human pathogen Staph-
ylococcus aureus uses for its defense against AMPs. These include an
AMP sensing system, which was the ﬁrst such system to be identiﬁed
in a Gram-positive bacterium, and various strategies of cell surface
modiﬁcation.
Modulation of the surface charge is a major theme inmicrobial AMP
resistance. Modiﬁcations of teichoic acids, lipopolysaccharides and
membrane lipids are usually regulated and only occur under AMP
stress. In contrast, many pathogens modify the actual cell wall core
structure, the peptidoglycan, constitutively. The modiﬁcation reactions
largely occur on the membrane-bound peptidoglycan building block,
the so-called Lipid II, which is a most prominent target for AMPs.
Münch and Sahl summarize the current knowledge on Lipid IImodiﬁca-
tions and their consequences for the interactions with various classes
of AMPs, such as defensins, lantibiotics and glyco-(lipo-)peptide
antibiotics.
Jerry Weiss studied mammalian Group IIA secretory phospholi-
pases A2 with high net positive charge and potent (nM) antibacterial
activity. The potency of sPLA2-IIA antibacterial activity reﬂects the
combination of initial charge-dependent, non-catalytic protein-
bacterial envelope interactions with catalytic events (membrane
phospholipid degradation) that are ultimately linked to bacterial in-
jury and death. The unique mechanism of action of the sPLA2-IIA
likely accounts for the antibacterial synergy that has been demon-
strated between the sPLA2-IIA and other host defense systems. Ex-
perimental dissection of the non-catalytic and catalytic interactions
of the sPLA2-IIA with target bacteria has made possible identiﬁcation
of speciﬁc bacterial properties and components that affect bacterial
sensitivity and resistance to the sPLA2-IIA in distinct ways. Compar-
ative studies with other cationic antimicrobial peptides and proteins
have revealed signiﬁcant differences in determinants of bacterial re-
sistance to sPLA2-IIA vs. other lower AMPs that may point the way to
future novel antibiotic combinations.
Octavio Franco and colleagues review multiple strategies by which
bacteria could develop enhanced antimicrobial peptide resistance,
focusing on sub-cellular regions from the surface to deep inside, evalu-
ating bacterial membranes, cell walls and cytoplasmic metabolism.
Moreover, some high-throughput methods for antimicrobial resistance
detection and discrimination are also examined.
3020 PrefacThe review by Shai et al. focuses on the mechanisms of bacterial
resistance against antimicrobial peptides via biophysical alterations
of the cell envelop. Overall, resistance to AMPs is due to changes in
bacterial surface, secretion of protectivematerial and changes in speciﬁc
proteins. Bacterial resistance to AMPs often involves biophysical and
biochemical changes to the bacterial cell wall.
Howdowe know thatmechanisms of AMPs resistance have a signif-
icance for bacterial survival during infection? Herein, Bauer and Shafer
review the literature on the use of animal model systems of infection
that employed isogenic strains of bacteria that differ in levels of suscep-
tibility to AMPs. They argue that even small (2–4 fold) differences in
AMP susceptibility can signiﬁcantly impact bacterial survival or ﬁtness
during experimental infections. They posit that AMP resistance systems
should be viewed as an important part of the overall pathogenic mech-
anisms employed by microbes during infection, which reinforces the
notion that AMPs are important mediators of innate host defense.
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